Dr Reddys Laboratories Ltd

NSE : DRREDDY06 Feb 2025
Pharmaceuticals
+9.10 (+0.74%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltd
Pharmaceuticals
NSE : DRREDDY06 Feb 2025
+9.10 (+0.74%)
1D
1M
6M
1Y
5Y
All

Dr Reddys Laboratories Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
0.71%
Upper Circuit
Lower Circuit
P/E TTM
19.9
P/B Ratio
3.83
Traded Value(Cr)
2.10
EPS TTM
62.12
Book value
Dividend
0.65%

Invest in Dr Reddys Laboratories Ltd at ZERO Brokerage for 30 days

Price Performance

3.92 %
1 Wk
-9.09 %
1 M
-3.51 %
3 M
0.71 %
1 Y
-10.33 %
YTD

Traded Volume Movement

Technical Details

Support 3
1203
Support 2
1217
Support 1
1227
Pivot Point :
1241
Resistance 1
1251
Resistance 2
1265
Resistance 3
1275

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Dr Reddys Laboratories Ltd
₹1,236.65(+9.10/0.74%)
1,236.65+9.10103,189.040.7119.903.83
Lupin Ltd
₹2,185.35(+0.25/0.01%)
2,185.35+0.2599,757.0838.9033.304.54
Ipca Laboratories Ltd
₹1,514.90(+23.45/1.57%)
1,514.90+23.4538,433.6531.4855.125.71
J B Chemicals & Pharmaceuticals Ltd
₹1,716.45(+2.65/0.15%)
1,716.45+2.6526,709.050.3242.538.47
383.60+8.102,251.94-14.2322.441.36
Sanofi India Ltd
₹5,519.45(+50.20/0.92%)
5,519.45+50.2012,711.29-37.7130.1418.56

About Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 103143.15 crores. It has reported a sales of Rs. 5081.8 crores and a net profit of Rs. 1034.8 crores for the quarter ended December 2018. The company management includes K Satish Reddy, G V Prasad,K Satish Reddy,Shikha Sanjaya Sharma,Leo Puri,K P Krishnan,Pennv Wan,K Randhir Singh,Arun M. Kumar,Claudio Albrecht,Sanjiv Mehta,Alpna Seth (Dr Reddys Laboratories Ltd) among others.
Chairman
K Satish Reddy
Registered office
8-2-337 Road No 3,Banjara Hills,Hyderabad,Telangana,500034
FAX :91-40-49002999
Background
Incorporation Year1984
Face Value₹5
Market Lot1

Latest News

Tech View: Nifty forms long red candle, uptrend intact above 23,800

Nifty formed a long negative candle on the daily chart on Thursday, which indicates an emergence of minor selling pressure from the highs. The index is currently placed at the overhead resistance of the down-sloping trend line around 23,800 levels. The bullish chart pattern like higher tops and bottoms is intact as per the daily timeframe chart.
06 Feb 2025 | 09:03 PM

📢 Sensex declines 213 points at the close; Nifty ends above 23,600

📈 Domestic benchmark indices closed on a negative note on 6 February, 2025.
📢 At 3:30 PM, the Sensex tanked by 213.12 points or 0.27% at 78,058.16, and the Nifty was down 92.95 points or 0.39% at 23,603.35.
📊Among sectoral, Nifty Pharma (⬆️0.64%) turned out to be the best performer while Nifty Midcap 100 (⬇️1.26%) saw considerable selling.
06 Feb 2025 | 03:41 PM

📢 Benchmark indices open on a flat note today; Nifty near 23,700

📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 129.76 points or 0.17% at 78,401.04 and the Nifty was up 22.10 points or 0.09% at 23,718.40.
📢Coforge (⬆️1.42%), Birlasoft (⬆️2.71%) and IEX (⬆️3.85%) appeared as the top performers on the Nifty50 at open.
06 Feb 2025 | 09:26 AM

📢 Sensex declines 213 points at the close; Nifty ends above 23,600

📈 Domestic benchmark indices closed on a negative note on 6 February, 2025.
📢 At 3:30 PM, the Sensex tanked by 213.12 points or 0.27% at 78,058.16, and the Nifty was down 92.95 points or 0.39% at 23,603.35.
📊Among sectoral, Nifty Pharma (⬆️0.64%) turned out to be the best performer while Nifty Midcap 100 (⬇️1.26%) saw considerable selling.
06 Feb 2025 | 03:41 PM

📢 Benchmark indices open on a flat note today; Nifty near 23,700

📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 129.76 points or 0.17% at 78,401.04 and the Nifty was up 22.10 points or 0.09% at 23,718.40.
📢Coforge (⬆️1.42%), Birlasoft (⬆️2.71%) and IEX (⬆️3.85%) appeared as the top performers on the Nifty50 at open.
06 Feb 2025 | 09:26 AM

How to buy Dr Reddys Laboratories Ltd shares on nse?

To buy Dr Reddys Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dr Reddys Laboratories Ltd share price today?

The Dr Reddys Laboratories Ltd shares price on nse is Rs.1236.65 today.

What is the market cap of Dr Reddys Laboratories Ltd shares on NSE ?

The company has a market capitalization of Rs.103189.04Cr

What is the PE & PB ratio of Dr Reddys Laboratories Ltd shares ?

PE is 19.9 and PB is 3.83

What is the 52 Week High and Low of Dr Reddys Laboratories Ltd shares?

Dr Reddys Laboratories Ltd stock price high: Rs.1421.49 Dr Reddys Laboratories Ltd stock price low: Rs.1120

Is Dr Reddy's Labs an effective investment?

As on 7th April, Dr Reddy’s Lab stock price has risen by 31.15% over the past 3 years. 

Investing in stocks, like any other capital investment, involves a certain amount of risk. To mitigate the risks, it's important to research, get professionals' help, and keep up-to-date with market trends.

What is the EPS of Dr Reddy's Labs shares?

For the quarter of Dec 2022, the EPS of Dr Reddy’s Labs was Rs. 74.7/ Share.

Who are the major stockholders of Dr Reddy's Labs shares?

The major stockholders of Dr Reddy’s Labs are: 

What is the ROI of Dr Reddy's Labs shares?

As on 7th April, Dr Reddy’s Labs has given an ROI of 8.53% over the past 12 months.

What are the primary indicators used to evaluate Dr Reddy's Labs?

There are several key parameters that investors may consider when evaluating whether to invest in Dr Reddy's Laboratories Ltd. :

  • Financial performance
  • Market position
  • Management quality
  • Valuation 
  • Regulatory compliance

How has the profitability of Dr Reddy's Labs Limited evolved over time?

Dr Reddy’s total standalone revenues have steadily grown over the past five years from Rs. 9563.3 crores in March 2018 to Rs. 14887.2 crores in March 2022. And the net profit increased from Rs. 566.9 crores to Rs. 1623.2 crores for the same period.